Microbial Contamination Control Strategies
Start with our introductory virtual lecture, jump directly into the hands-on, in-person track that matches your process, or bundle into a comprehensive multi-day progression. Though not required, the introductory lecture material is assumed background knowledge for the in-person workshops.
Three courses
CGMP & Cleanroom Microbiology: An Introduction to Microbial Contamination Control
Pick your date to register in the first accordion below
Contamination Control Strategies and RCA/CAPA in Drug Substance Manufacturing
Register
Contamination Control Strategies and RCA/CAPA for Aseptic Processing and Cleanroom Environments
Register
CGMP & Cleanroom Microbiology: An Introduction to Microbial Contamination Control
This fully virtual introductory course covers how to detect, identify, and prevent microbial contamination—specifically designed for non-microbiologists.
- Overview of bioprocessing (drug substance) and sterile manufacturing (drug product). Terminal sterilization versus aseptic production
- Most common microbial contaminants in bioprocessing and aseptic operations
- Microbial contamination detection methods including bioburden, sterility, and endotoxin testing
- Environmental Monitoring for viable and non-viable particles. Alert and Action levels.
- Microbial identification methods and technologies
- Sanitization, disinfection, and sterilization methods
- Biological indicators
- Aseptic technique and best practices for working with LAF/BSC hoods
- Case studies on microbial contamination events
- Root cause analysis (RCA) and CAPA plans
8:30 a.m. to 12:30 p.m., EST
Registration fee: $150
Contamination Control Strategies and RCA/CAPA in Drug Substance Manufacturing
Track A is a one-day, in-person course covering contamination control strategies (CCS) in CGMP bioprocessing environments for drug substance (DS) and bulk API production. The day will be split between a lecture covering the essential contamination control knowledge for drug substance manufacturing and aseptic technique practice and RCA/CAPA exercises. As the pharmaceutical industry continues to evolve and face new challenges, the CCS has become a critical pharmaceutical quality document.
- Lecture Topics
- Contamination control and detection strategies
- Focus on equipment, facilities, process, materials, clean utilities, and personnel
- Equipment cleaning – CIP and COP
- Contamination control and detection strategies
- Hands-On Activities
- Aseptic technique and operations in a LAF/BSC hood
- Contamination case studies/troubleshooting contamination events
- Root cause analysis (RCA) and CAPA plans
- Learn how to develop a contamination control strategy using quality risk management
- Overview of key regulatory and industry guidance documents including EU Annex 1 (2022/2023), PDA TR#90, and ICH Q10.
January 26, 2027
Registration fee: $975
Contamination Control Strategies and RCA/CAPA for Aseptic Processing and Cleanroom Environments
Track B is a one-day, in-person course covering contamination control strategies in aseptic/sterile, fill-finish, drug product (DP) environments. The day will be split between a lecture covering the essentials of aseptic environments, environmental monitoring techniques, and aseptic technique practice and RCA/CAPA exercises.
- Lecture Topics
- Sterile Fill Finish – Aseptic processing concepts and controls
- Cleanroom design and classification
- RABS and Isolators – design and controls
- Air visualization/smoke studies
- Media fills
- Sterile filtration concepts
- EM during aseptic processing
- Aseptic gowning/qualification
- Personnel monitoring
- Depyrogenation concepts
- Container Closure Integrity Testing
- Filter integrity testing
- Hands-On Activities
- Perform filter integrity tests
- Aseptic technique and operations in a LAF/BSC hood
- Case studies – Sterility test failure and media fill failure investigations
- Root cause analysis (RCA) and CAPA plans
- Learn how to develop a contamination control strategy document using quality risk management
- Overview of key regulatory and industry guidance documents including EU Annex 1 (2022/2023), PDA TR#90, and ICH Q10.
January 27, 2027
Registration fee: $975

Lucia Clontz, D. H.Sc., M.S., is the President of Clontz Consulting, Inc. Formerly the site Quality Head for Xellia Pharmaceuticals in Raleigh, she has 40 years of industry experience in quality, pharmaceutical microbiology, laboratory management, operational excellence initiatives, and training. She is a published author, speaker, and workshop leader at both national and international conferences, and in 2004, she received the Parenteral Drug Association’s Distinguished Editor/Author award. She currently holds an appointment as a BTEC Teaching Fellow and also serves as a member of the United States Pharmacopeia (USP) Pharmaceutical Waters Expert Panel (2010–2030).